table of content
1 Introduction to Research & Analysis Reports
1.1 Gene-based Advanced Therapy Medicinal Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-based Advanced Therapy Medicinal Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-based Advanced Therapy Medicinal Overall Market Size
2.1 Global Gene-based Advanced Therapy Medicinal Market Size: 2022 VS 2030
2.2 Global Gene-based Advanced Therapy Medicinal Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-based Advanced Therapy Medicinal Players in Global Market
3.2 Top Global Gene-based Advanced Therapy Medicinal Companies Ranked by Revenue
3.3 Global Gene-based Advanced Therapy Medicinal Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Advanced Therapy Medicinal Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene-based Advanced Therapy Medicinal Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Players in Global Market
3.6.1 List of Global Tier 1 Gene-based Advanced Therapy Medicinal Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene-based Advanced Therapy Medicinal Market Size Markets, 2022 & 2030
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
4.2.1 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
4.2.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
4.2.3 By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2030
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
5.2.1 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
5.2.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
5.2.3 By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2030
6.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
6.2.1 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
6.2.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
6.2.3 By Region - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.3.2 US Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.4.2 Germany Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.3 France Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.4 U.K. Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.5 Italy Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.6 Russia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.7 Nordic Countries Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.8 Benelux Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.5.2 China Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.3 Japan Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.4 South Korea Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.5 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.6 India Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.6.2 Brazil Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.6.3 Argentina Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.7.2 Turkey Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.3 Israel Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.4 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.5 UAE Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.1.4 Biogen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene-based Advanced Therapy Medicinal Major Product Offerings
7.2.4 Novartis Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Major Product Offerings
7.3.4 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.6.4 Amgen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.7.4 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News
7.9 Sunway Biotech
7.9.1 Sunway Biotech Corporate Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Major Product Offerings
7.9.4 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.9.5 Sunway Biotech Key News
7.10 SIBIONO
7.10.1 SIBIONO Corporate Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Major Product Offerings
7.10.4 SIBIONO Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.10.5 SIBIONO Key News
7.11 AnGes
7.11.1 AnGes Corporate Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene-based Advanced Therapy Medicinal Major Product Offerings
7.11.4 AnGes Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.11.5 AnGes Key News
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Corporate Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.12.4 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics Key News
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Corporate Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Major Product Offerings
7.13.4 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.13.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
